Susquehanna International Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187K Sell
14,648
-552
-4% -$12.3K ﹤0.01% 12022
2026
Q1
$401K Sell
15,200
-21,934
-59% -$2.76M ﹤0.01% 10206
2025
Q4
$9.21M Sell
37,134
-4,136
-10% -$944K ﹤0.01% 3150
2025
Q3
$8.68M Buy
41,270
+25,949
+169% +$4.58M ﹤0.01% 3223
2025
Q2
$1.51M Buy
15,321
+3,190
+26% +$278K ﹤0.01% 6431
2025
Q1
$1.07M Buy
12,131
+9,993
+467% +$924K ﹤0.01% 7100
2024
Q4
$154K Buy
2,138
+1,337
+167% +$91.6K ﹤0.01% 10993
2024
Q3
$63.5K Sell
801
-417
-34% -$32.1K ﹤0.01% 11286
2024
Q2
$87.7K Sell
1,218
-16
-1% -$958 ﹤0.01% 11110
2024
Q1
$116K Buy
1,234
+404
+49% +$35.6K ﹤0.01% 11113
2023
Q4
$60.4K Sell
830
-708
-46% -$41.8K ﹤0.01% 11636
2023
Q3
$102K Buy
1,538
+1,373
+832% +$127K ﹤0.01% 10902
2023
Q2
$15.8K Sell
165
-1,674
-91% -$167K ﹤0.01% 11683
2023
Q1
$185K Buy
1,839
+1,110
+152% +$170K ﹤0.01% 10693
2022
Q4
$127K Sell
729
-3,037
-81% -$2M ﹤0.01% 10707
2022
Q3
$3.61M Sell
3,766
-623
-14% -$619K ﹤0.01% 3721
2022
Q2
$2.94M Sell
4,389
-394
-8% -$244K ﹤0.01% 4115
2022
Q1
$3.32M Buy
4,783
+4,382
+1,093% +$3.38M ﹤0.01% 4427
2021
Q4
$363K Sell
401
-578
-59% -$549K ﹤0.01% 10022
2021
Q3
$984K Buy
979
+670
+217% +$493K ﹤0.01% 7593
2021
Q2
$201K Sell
309
-210
-40% -$146K ﹤0.01% 11590
2021
Q1
$384K Buy
519
+73
+16% +$58.9K ﹤0.01% 10074
2020
Q4
$345K Buy
446
+63
+16% +$49.6K ﹤0.01% 8994
2020
Q3
$380K Sell
383
-71
-16% -$75.3K ﹤0.01% 8240
2020
Q2
$472K Buy
+454
New +$457K ﹤0.01% 7479
2019
Q4
– Sell
-175
Closed -$235K – 10035
2019
Q3
$235K Buy
+175
New +$278K ﹤0.01% 8791

Other funds holding GOSS

Susquehanna International Group's GOSS Position: Q2 2026 in Review

Susquehanna International Group increased its Gossamer Bio (GOSS) stake by 182% in Q2 2026, buying an estimated $69K and bringing the position to 4,788 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #12748.

Susquehanna International Group first reported a position in GOSS in Q3 2019 and has held it in 24 quarters since. The position peaked at $3.21M in Q1 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Susquehanna International Group held 4,788 shares of Gossamer Bio worth $63K as of Q2 2026.
  • Susquehanna International Group bought 3,091 Gossamer Bio shares in Q2 2026, an estimated $69K.
  • Gossamer Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12748 holding.
  • Susquehanna International Group first reported a position in Gossamer Bio in Q3 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's Gossamer Bio position peaked at $3.21M in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.